Sep 7, 2025, 13:37
Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
RPTH Journal shared on LinkedIn:
”ECMO is life-saving technology!
What is better for patient outcomes? This review compares low dose vs standard unfractionated heparin on patient morbidity and mortality.”
Read the full article here.
Article: Mortality and Complications in Low-Dose versus Standard-Dose Unfractionated Heparin Anticoagulation for Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Authors: Wincy Wing-Sze Ng, Rex Wan-Hin Hui, Ka-Chun Leung, Pauline Yeung Ng, Chun-Wai Ngai, Simon Wai-Ching Sin, Chun-Fung Sin
Stay updated on the latest scientific advances in the field of coagulation with Hemostasis Today.
-
Feb 16, 2026, 06:21C. Michael Gibson: Favorable Safety Outcomes With Asundexian
-
Feb 16, 2026, 06:18Jecko Thachil: What Do Clinicians Mean by “Coagulopathy”?
-
Feb 16, 2026, 06:04Inside 2026 Highlights of ASH in the Mediterranean, Middle East, and North Africa with Dr. Heghine Khachatryan
-
Feb 15, 2026, 10:56Don’t Miss PNH: Clinical Practice From ISTH – Medscape
-
Feb 15, 2026, 10:52Awareness and Research on Factor V Deficiency Are Critical – EHC
-
Feb 15, 2026, 10:43Peter Zdziarski: Protecting Patient Data in the Rare Disease Community
-
Feb 15, 2026, 10:31Michiel Voet: The Price Tag of a Whole Blood Strategy
-
Feb 15, 2026, 10:26Sifat Jubaira: K₂-EDTA vs K₃-EDTA – Same Anticoagulant, Very Different Accuracy
-
Feb 15, 2026, 09:29Gevorg Tamamyan: Childhood Cancer is Curable. Inequity Is Not